MENU

SER Serina Therapeutics Forecast, Technical & Fundamental Analysis

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain... Show more

SER
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
SER
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

SER is expected to report earnings to fall 38.18% to -34 cents per share on November 18

Serina Therapeutics SER Stock Earnings Reports
Q3'26
Est.
$-0.34
Q2'26
Missed
by $0.09
The last earnings report on August 13 showed earnings per share of -55 cents, missing the estimate of -46 cents. With 46.26K shares outstanding, the current market capitalization sits at 51.05M.
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WMT116.163.88
+3.46%
Walmart
TLNC10.21N/A
N/A
Talon Capital Corp
ACA147.06-0.19
-0.13%
Arcosa
DEI9.29-0.54
-5.49%
Douglas Emmett
SOGP10.65-0.73
-6.41%
Sound Group

SER and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SER has been loosely correlated with GERN. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if SER jumps, then GERN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SER
1D Price
Change %
SER100%
-6.19%
GERN - SER
65%
Loosely correlated
-1.64%
XTLB - SER
59%
Loosely correlated
+1.56%
ELVN - SER
37%
Loosely correlated
-3.31%
TOVX - SER
34%
Loosely correlated
-1.69%
LIFE - SER
34%
Loosely correlated
+6.02%
More
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Industry
N/A
Address
601 Genome Way
Phone
+1 256 327-9630
Employees
16
Web
https://www.serinatherapeutics.com
Serina Therapeutics (SER) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com